Bandaram Pharma Packtech

Bandaram Pharma Packtech FCF Conversion

Delisted·Sep 16, 2026

The FCF Conversion Rate (FCF/EBITDA) of Bandaram Pharma Packtech (524602.BO) as of Nov 3, 2026 is -504.35 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was -454.63 % — a change of 10.94% (lower).

FCF Conversion

-504.35 %

YoY

10.94%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Bandaram Pharma Packtech is 2025 -504.35 % . FCF Conversion Rate (FCF/EBITDA) of Bandaram Pharma Packtech was 2024 -454.63 % . It decreases by 10.94% lower compared to the previous year.

The Bandaram Pharma Packtech FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2021
0.00 INR
Jan 1, 2022
-28,747.14 INR
Jan 1, 2023
-2,747.78 INR
Jan 1, 2024
-454.63 INR
Jan 1, 2025
-504.35 INR
The Bandaram Pharma Packtech FCF Conversion history
YEARFCF ConversionYoY
-504.35 %+10.94%
-454.63 %-83.45%
-2,747.78 %-90.44%
-28,747.14 %—
0.00—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bandaram Pharma Packtech Stock analysis

What does Bandaram Pharma Packtech do? Bandaram Pharma Packtech Ltd. manufactures pharmaceutical products and supplies recycled paper to small and medium sized paper mills in East and West Godavari Districts of Andhra Pradesh. The company serves the pharma, food and beverages industries with its products. Its subsidiary VSR Paper and Packaging Limited supports its operations in the packaging sector. The firm primarily processes and supplies various categories of recycled paper, both imported and indigenous, to paper mills. These mills then use the paper to produce packaging for pharmaceutical, food, and beverage companies. Bandaram Pharma Packtech Ltd. generates revenue through the sale of recycled paper materials to these mills. VSR Paper and Packaging Limited, as a subsidiary, likely contributes to the company's revenue by providing specialized packaging solutions for the pharma, food, and beverage sectors. The company's core business model revolves around supplying raw materials to paper mills that serve the pharma and food industries. Bandaram Pharma Packtech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bandaram Pharma Packtech stock

FCF Conversion Rate (FCF/EBITDA) of Bandaram Pharma Packtech is -504.35 % in 2025.

FCF Conversion Rate (FCF/EBITDA) of Bandaram Pharma Packtech changed from -454.63 % to -504.35 %, representing a 10.94% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Bandaram Pharma Packtech since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Bandaram Pharma Packtech with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Bandaram Pharma Packtech

All Key Metrics — Bandaram Pharma Packtech